Prosecution Insights
Prosecution Insights
10 pending office actions • 8 art units • 10 examiners • 0 of 10 (0%) have an AI response strategy ready • 4 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 10 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 10 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (10%) |
| §103 only | 7 (70%) |
| §112 only | 2 (20%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| TANINGCO, MARCUS H | 1 | 80.9% | +6.5% |
| SHIM, DAVID M. | 1 | 58.8% | +56.0% |
| KIKNADZE, IRAKLI | 1 | 88.9% | +8.1% |
| EIX, EMILY FAY | 1 | 52.2% | +64.7% |
| PIPIC, ALMA | 1 | 54.5% | +55.6% |
| EMCH, GREGORY S | 1 | 49.0% | +44.3% |
| ABBOTT, KODYE LEE | 1 | 52.4% | +62.5% |
| FRITCHMAN, REBECCA M | 1 | 45.7% | +36.1% |
| BARRON, SEAN C | 1 | 53.5% | +30.9% |
| WOZNICKI, JACQUELINE | 1 | 49.7% | +27.0% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18549848 | Target for calibrating and determining the spatial resolution, SNR and/or CNR associated with an XCT system | KIKNADZE, IRAKLI | 114d overdue |
| 18292628 | Spatial Modulator for Terahertz Radiation | TANINGCO, MARCUS H | 43d overdue |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18086719 | GENE THERAPY | ABBOTT, KODYE LEE | 16d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18041141 | NANOPARTICLE-ENABLED ANALYSIS OF CELL-FREE NUCLEIC ACID IN COMPLEX BIOLOGICAL FLUIDS | EMCH, GREGORY S | 67d overdue |
| 17598965 | Method of Sialylating a Protein | BARRON, SEAN C | 46d overdue |
| 17438345 | TISSUE REPAIR SCAFFOLD AND DEVICE | WOZNICKI, JACQUELINE | 44d overdue |
| 17760249 | Detection of Lipid Markers | FRITCHMAN, REBECCA M | 43d overdue |
| 17926847 | ANTIVIRAL POLYMERS | PIPIC, ALMA | 25d overdue |
| 18291809 | 6-SUBSTITUTED NAPHTHALENE-1,3-DISULFONIC ACID DERIVATIVES AS MODULATORS OF THE EXTRACELLULAR NICOTINAMIDE PHOSPHORIBOSYL TRANSFERASE (ENAMPT) FOR THE TREATMENT OF E.G. DIABETES | SHIM, DAVID M. | 12d |
| 18086719 | GENE THERAPY | ABBOTT, KODYE LEE | 16d |
| 18277434 | ADAMTS13 VARIANT | EIX, EMILY FAY | 34d |
| Art Unit | Apps |
|---|---|
| 2884 | 2 |
| 1653 | 2 |
| 1626 | 1 |
| 1617 | 1 |
| 1678 | 1 |
| 1634 | 1 |
| 1758 | 1 |
| 3774 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18292628 | Spatial Modulator for Terahertz Radiation | TANINGCO, MARCUS H | 2884 | §103 | Non-Final OA | 43d overdue | Pending | Jan 26, 2024 |
| 18291809 | 6-SUBSTITUTED NAPHTHALENE-1,3-DISULFONIC ACID DERIVATIVES AS MODULATORS OF THE EXTRACELLULAR NICOTINAMIDE PHOSPHORIBOSYL TRANSFERASE (ENAMPT) FOR THE TREATMENT OF E.G. DIABETES | SHIM, DAVID M. | 1626 | §112 | Non-Final OA | 12d | Pending | Jan 24, 2024 |
| 18549848 | Target for calibrating and determining the spatial resolution, SNR and/or CNR associated with an XCT system | KIKNADZE, IRAKLI | 2884 | §112 | Non-Final OA | 114d overdue | Pending | Sep 08, 2023 |
| 18277434 | ADAMTS13 VARIANT | EIX, EMILY FAY | 1653 | §103 | Non-Final OA | 34d | Pending | Aug 16, 2023 |
| 17926847 | ANTIVIRAL POLYMERS | PIPIC, ALMA | 1617 | §103 | Non-Final OA | 25d overdue | Pending | Jul 19, 2023 |
| 18041141 | NANOPARTICLE-ENABLED ANALYSIS OF CELL-FREE NUCLEIC ACID IN COMPLEX BIOLOGICAL FLUIDS | EMCH, GREGORY S | 1678 | §103 | Non-Final OA | 67d overdue | Pending | Feb 09, 2023 |
| 18086719 | GENE THERAPY | ABBOTT, KODYE LEE | 1634 | §101 | Non-Final OA | 16d | Pending | Dec 22, 2022 |
| 17760249 | Detection of Lipid Markers | FRITCHMAN, REBECCA M | 1758 | §103 | Final Rejection | 43d overdue | Pending | Aug 05, 2022 |
| 17598965 | Method of Sialylating a Protein | BARRON, SEAN C | 1653 | §103 | Non-Final OA | 46d overdue | Pending | Sep 28, 2021 |
| 17438345 | TISSUE REPAIR SCAFFOLD AND DEVICE | WOZNICKI, JACQUELINE | 3774 | §103 | Non-Final OA | 44d overdue | Pending | Sep 10, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial